Human medicines European public assessment report (EPAR): Zurzuvae, zuranolone, Status: Authorised
Human medicines European public assessment report (EPAR): Empliciti, elotuzumab, Date of authorisation: 11/05/2016, Revision: 13, Status: Authorised
Human medicines European public assessment report (EPAR): ellaOne, ulipristal acetate, Date of authorisation: 15/05/2009, Revision: 36, Status: Authorised
HMA-EMA joint Network Data Steering Group meeting - 17 July 2025
List of signals discussed at PRAC since September 2012
PRAC recommendations on signals adopted at the 1-4 September 2025 PRAC meeting
New product information wording: extracts from PRAC recommendations on signals adopted at the 1-4 September 2025 PRAC
Human medicines European public assessment report (EPAR): Blitzima, rituximab, Date of authorisation: 13/07/2017, Revision: 24, Status: Authorised
A path to better include patients’ perspectives in the regulation of medicines
Human medicines European public assessment report (EPAR): Ibandronic acid Accord, ibandronic acid, Date of authorisation: 18/11/2012, Revision: 17, Status: Authorised